Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | GLA | P06280 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.60 |
| ▸ | CASP1 | P29466 | 1/20 | 0.60 |
| ▸ | CASP7 | P55210 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 5/20 | 0.58 |
| ▸ | RAB9A | P51151 | 5/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.56 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.56 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | TTR | P02766 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3091546 | 0.90 | MAOA (0.60) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL30999865 | 0.90 | MAOA (0.60) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL30810814 | 0.90 | AHR (0.53) | MAOAKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL10306815 | 0.90 | AHR (0.53) | MAOAKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL10884700 | 0.88 | HTR1A (0.48) | MAOAKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL18798555 | 0.88 | NPC1 (0.62) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL18242719 | 0.87 | MAOA (0.56) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL18242248 | 0.84 | MAOA (0.53) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL9851917 | 0.83 | KIF11 (0.44) | MAOAKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL8711547 | 0.83 | MAOA (0.60) | MAOAKDM4EALDH1A1GLACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| US-9637565-B2 | Photoinitiating system for anionic polymerization | UVIC INDUSTRY PARTNERSHIPS INC. (US) | 2017-05-02 | — | — | US | disclosed |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
| US-20050028895-A1 | Radiation curable precious metal preparation, transfers containing same and method for decoration | FERRO GMBH (DE) | 2005-02-10 | — | — | US | disclosed |
| EP-1291335-B1 | Radiation curable precious metal composition, decalcomanias containing it and method of decorating | FERRO GMBH (DE) | 2004-08-11 | — | — | EP | disclosed |
| WO-2003022781-A1 | RADIATION CURABLE PRECIOUS METAL PREPARATION, TRANSFERS CONTAINING SAME AND METHOD FOR DECORATION | FERRO GMBH (DE) | 2003-03-20 | — | — | WO | disclosed |
| EP-1291335-A1 | Radiation curable precious metal composition, decalcomanias containing it and method of decorating | OMG AG & Co. KG (DE) | 2003-03-12 | — | — | EP | disclosed |
| US-4379039-A | Ultraviolet curable resin composition | TOYO BOSEKI KABUSHIKI KAISH (JP) | 1983-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | CBR1, HAO2, CBR3 | MAOA 403/4885KDM4E 4342/4885ALDH1A1 151/4885 |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | CBR1, HAO2, CBR3 | MAOA 403/4885KDM4E 4342/4885ALDH1A1 151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.